Resolving disputes about toxicological risks during military conflict: The US gulf war experience

Toxicological Reviews

Volumn 24, Issue 3, 2005, Pages 167-180

  Hyams, Kenneth C ^a,c   Brown, Mark ^a   White, David S ^b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b United Kingdom Ministry of Defence   (United States)

^c Veterans Administration Central Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOXIC SUBSTANCE;

ARMY; CLINICAL EXAMINATION; CONFLICT; ECOTOXICITY; ENVIRONMENTAL EXPOSURE; HEALTH; HEALTH HAZARD; HUMAN; MEDICAL ASSESSMENT; MEDICAL DOCUMENTATION; MEDICAL EXPERT; OCCUPATIONAL EXPOSURE; PEER REVIEW; PUBLICATION; REVIEW; RISK ASSESSMENT; SCIENTIFIC LITERATURE; UNITED KINGDOM; UNITED STATES; VETERAN; WAR;

EXPERT TESTIMONY; GREAT BRITAIN; GULF WAR; HEALTH STATUS; MILITARY PERSONNEL; PERSIAN GULF SYNDROME; RISK ASSESSMENT; TOXICOLOGY; UNITED STATES; VETERANS;

EID: 30344464965     PISSN: 11762551     EISSN: 11762551     Source Type: Journal    
DOI: 10.2165/00139709-200524030-00009     Document Type: Review

References (141)

1. Leyden AP, editor. Gulf War debriefing book: an after action report. Grants Pass (OR): Hellgate Press, 1997
2. Data on file, US Defense Manpower Data Center, Seaside (CA), 2005
3. Data on file. UK Ministry of Defence, London, 2005
4. Writer JV, DeFraites RF, Brundage JF. Comparative mortality among US military personnel in the Persian Gulf region and worldwide during Operations Desert Shield and Desert Storm. JAMA 1996; 275: 118-21
5. Persian Gulf Veterans Coordinating Board. Unexplained illnesses among Desert Storm veterans: a search for causes, treatment, and cooperation. Arch Intern Med 1995; 155: 262-8
6. Q&A: 'Iraq War Syndrome'. BBC News 2003 May 27 [online]. Available from URL: http://news.bbc.co.uk/2/hi/health/2940214.stm [Accessed 2005 Aug 31]
7. Murphy FM. Gulf War syndrome. BMJ 1999; 318: 274-5
8. Wegman DH, Woods NF, Bailar JC. Invited commentary: how would we know a Gulf War syndrome if we saw one? Am J Epidemiol 1997; 146: 704-11
9. Haley RW. Is Gulf War syndrome due to stress? The evidence reexamined. Am J Epidemiol 1997; 146: 695-703
10. Hoge CW, Castro CA, Messer SC, et al. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med 2004; 351: 13-22
11. Reeves RR, Parker JD, Konkle-Parker DJ. War-related mental health problems of today's veterans: new clinical awareness. J Psychosoc Nurs Ment Health Serv 2005; 43: 18-28
12. Hughes JH, Cameron F, Eldridge R, et al. Going to war does not have to hurt: preliminary findings from the British deployment to Iraq. Br J Psychiatry 2005; 186: 536-7
13. Miscellanea medica. JAMA 1992; 267: 2579
14. DeFraites RF, Wanat ER, Norwood AE, et al. Report, investigation of a suspected outbreak of an unknown disease among veterans of Operation Desert Shield/Storm, 123d Army Reserve Command, Fort Benjamin Harrison, Indiana, April, 1992. Washington, DC: Epidemiology Consultant Service (EPICON), Division of Preventive Medicine, Walter Reed Army Institute of Research, 1992
15. Murphy F, Browne D, Mather S, et al. Women in the Persian Gulf War: implications for active duty troops and veterans. Mil Med 1997; 162: 656-60
16. Murphy FM, Kang H, Dalager NA, et al. The health status of Gulf War veterans: lessons learned from the Department of Veterans Affairs Health Registry. Mil Med 1999; 164: 327-31
17. Combined Analysis of the VA and DoD Gulf War Clinical Evaluation Programs. A study of the clinical findings from systematic medical examinations of 100,339 US Gulf War veterans. Department of Veterans Affairs, Veterans Health Administration, and Department of Defense, Office of the Assistant Secretary of Defense, Health Affairs, September 2002 [online]. Available from URL: http://www1.va.gov/gulfwar/docs/combinedRegistryanalysis2_.pdf [Accessed 2005 Aug 31]
18. Joseph SC, and the Comprehensive Clinical Evaluation Program Evaluation Team. A comprehensive clinical evaluation of 20,000 Gulf War veterans. Mil Med 1997; 162: 149-55
19. Lee HA, Gabriel R, Bale AJ, et al. Clinical findings of the second 1000 UK Gulf War veterans who attended the Ministry of Defence's Medical Assessment Programme. J R Army Med Corps 2001; 147: 153-60
20. Lee HA, Gabriel R, Bolton JP, et al. Health status and clinical diagnoses of 3000 UK Gulf War veterans. J R Soc Med 2002; 95: 491-7
21. Robinson A. Veterans worry that unexplained medical problems a legacy of service during Gulf War. CMAJ 1995; 152: 944-7
22. Kelsall HL, Sim MR, Forbes AB, et al. Symptoms and medical conditions in Australian veterans of the 1991 Gulf War: relation to immunisations and other Gulf War exposures. Occup Environ Med 2004; 61: 1006-13
23. Kang HK, Hyams KC. Mental health care needs among recent war veterans. N Engl J Med 2005; 352: 1289
24. Kroenke K, Mangelsdorff AD. Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Am J Med 1989; 86: 262-6
25. Kroenke K, Spitzer RL, Williams JBW, et al. Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med 1994; 3: 774-9
26. Marple RL, Kroenke K, Lucey CR, et al. Concerns and expectations in patients presenting with physical complaints: frequency, physician perceptions and actions, and 2-week outcome. Arch Intern Med 1997; 157: 1482-8
27. Hull L, David AS, Hyams KC, et al. Self-reported health of Persian Gulf War veterans: a comparison of help-seeking and randomly ascertained cases. Mil Med 2002; 167: 747-52
28. Hyams KC, Roswell RH. Resolving the Gulf War syndrome question. Am J Epidemiol 1998; 148: 339-42
29. Lee HA, Bale AJ, Gabriel R. Results of investigations on Gulf War veterans. Clin Med 2005; 5: 1-7
30. Department of Veterans Affairs, Deployment Health Working Group Research Subcommittee. Annual report to Congress: federally sponsored research on Gulf War Veterans' Illnesses for 2002 [online]. 2004 Apr. Available from URL: http://www1.va.gov/resdev/resources/pubs/GulfWarRpt02.cfm [Accessed 2005 Aug 31]
31. Department of Veterans Affairs Press Release. VA announces funding for Gulf War illnesses [online]. 2004 Nov 12. Available from URL: http://www1.va.gov/opa/pressrel/PressArtInternet.cfm?.id=896 [Accessed 2005 Aug 31]
32. The Iowa Persian Gulf Study Group. Self-reported illness and health status among Gulf War veterans. JAMA 1996; 277: 238-45
33. Fukuda K, Nisenbaum R, Stewart G, et al. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA 1998; 280: 981-8
34. Unwin C, Blatchley N, Coker W, et al. The health of United Kingdom servicemen who served in the Persian Gulf War. Lancet 1999; 353: 169-78
35. Cherry N, Creed F, Silman A, et al. Health and exposures of United Kingdom Gulf War veterans. Part I: the pattern and extent of ill health. Occup Environ Med 2001; 58: 291-8
36. Kang HK, Mahan CM, Lee KY, et al. Illnesses among United States Veterans of the Gulf War: a population-based survey of 30,000 veterans. J Occup Environ Med 2000; 42: 1-11
37. Goss Gilroy Inc. Canadian Epidemiological Study of Gulf War Veterans [online]. 1998 Jun. Available from URL: http://www.forces.gc.ca/site/reports/ Health/vol1_TOC_e.asp and http://www.forces.gc.ca/site/reports/Health/ vol2_TOC_e.asp [Accessed 2005 Aug 31]
38. Steele L. Prevalence and patterns of Gulf War illness in Kansas veterans: association of symptoms with characteristics of person, place, and time of military service. Am J Epidemiol 2000; 152: 992-1002
39. Gray GC, Coate BD, Anderson CM, et al. The postwar hospitalization experience of U.S. veterans of the Persian Gulf War. N Engl J Med 1996; 335: 1505-13
40. Gray GC, Smith TC, Kang HK, et al. Are Gulf War veterans suffering war-related illnesses? Federal and civilian hospitalizations examined, June 1991 to December 1994. Am J Epidemiol 2000; 151: 63-71
41. Everson MP, Shi K, Aldridge P, et al. Immunological responses are not abnormal in symptomatic Gulf War veterans. Ann N Y Acad Sci 2002; 966: 327-42
42. Amato AA, McVey A, Cha C, et al. Evaluation of neuromuscular symptoms in veterans of the Persian Gulf War. Neurology 1997; 48: 4-12
43. Krivda SJ, Roy MJ, Chung RCY, et al. Cutaneous findings in Gulf War veterans. Arch Dermatol 1996; 132: 846-7
44. Penman AD, Currier MM, Tarver RS. No evidence of increase in birth defects and health problems among children born to Persian Gulf War veterans in Mississippi. Mil Med 1996; 161: 1-6
45. Cowan DN, DeFraites RF, Gray GC, et al. A records-based evaluation of the risk of birth defects among children of Gulf War veterans. N Engl J Med 1997; 336: 1650-6
46. Araneta MR, Destiche DA, Schlangen KM, et al. Birth defects prevalence among infants of Persian Gulf War veterans born in Hawaii, 1989-1993. Teratology 2000; 62: 195-204
47. Kang H, Magee C, Mahan C, et al. Pregnancy outcomes among US Gulf War veterans: a population-based survey of 30,000 veterans. Ann Epidemiol 2001; 11: 504-11
48. Araneta MR, Schlangen KM, Edmonds LD, et al. Prevalence of birth defects among infants of Gulf War veterans in Arkansas, Arizona, California, Georgia, Hawaii, and Iowa, 1989-1993. Birth Defects Res A Clin Mol Teratol 2003; 67: 246-60
49. Araneta MR, Moore CA, Olney RS, et al. Goldenhar syndrome among infants born in military hospitals to Gulf War veterans. Teratology 1997; 56: 244-51
50. Sutker PB, Uddo M, Brailey K, et al. War-zone trauma and stress-related symptoms in Operation Desert Shield/Storm (ODS) returnees. J Soc Issues 1993; 49: 33-49
51. Stretch RH, Wright KM, Bliese PD, et al. Physical health symptomatology of Gulf War-era service personnel from the states of Pennsylvania and Hawaii. Mil Med 1995; 160: 131-6
52. Ford JD, Campbell KA, Storzbach D, et al. Posttraumatic stress symptomatology is associated with unexplained illness attributed to Persian Gulf War military service. Psychosom Med 2001; 63: 842-9
53. Roy MJ, Koslowe PA, Kroenke K, et al. Signs, symptoms, and ill-defined conditions in Persian Gulf War veterans: findings from the comprehensive clinical evaluation program. Psychosom Med 1998; 60: 663-8
54. Ikin JF, Sim MR, Creamer MC, et al. War-related psychological stressors and risk of psychological disorders in Australian veterans of the 1991 Gulf War. Br J Psychiatry 2004; 185: 116-26
55. Gray GC, Kaiser KS, Hawksworth AW, et al. Increased postwar symptoms and psychological morbidity among US Navy Gulf War veterans. Am J Trop Med Hyg 1999; 60: 758-66
56. Haley RW, Kurt TL, Horn J. Is there a Gulf War syndrome? Searching for syndromes by factor analysis of symptoms. JAMA 1997; 277: 215-22
57. Haley RW, Horn J, Roland PS, et al. Evaluation of neurologic function in Gulf War veterans: a blinded case-control study. JAMA 1997; 277: 223-30
58. Haley RW, Kurt TL. Self-reported exposure to neurotoxic chemical combinations in the Gulf War: a cross-sectional epidemiologic study. JAMA 1997; 277: 231-7
59. Horn J, Haley RW, Kurt TL. Neuropsychological correlates of Gulf War syndrome. Arch Clin Neuropsychol 1997; 12: 531-44
60. Haley RW, Billecke S, LaDu BN. Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol Appl Pharmacol 1999; 157: 227-33
61. Haley RW, Marshall WW, McKonald GG, et al. Brain abnormalities in Gulf War syndrome: evaluation with 1H MR spectroscopy. Radiology 2000; 215: 807-17
62. Haley RW, Fleckenstein JL, Marshall WW, et al. Effect of basal ganglia injury on central dopamine activity in Gulf War syndrome: correlation of proton magnetic resonance spectroscopy and plasma homovanillic acid levels. Arch Neurol 2000; 57: 1280-5
63. Roland PS, Haley RW, Yellin W, et al. Vestibular dysfunction in Gulf War syndrome. Otolaryngol Head Neck Surg 2000; 122: 319-29
64. Haley RW, Luk GD, Petty F. Use of structural equation modeling to test the construct validity of a case definition of Gulf War syndrome: invariance over developmental and validation samples, service branches and publicity. Psychiatry Res 2001; 102: 175-200
65. Haley RW, Maddrey AM, Gershenfeld HK. Severely reduced functional status in veterans fitting a case definition of Gulf War syndrome. Am J Public Health 2002; 92: 46-7
66. Haley RW, Vongpatanasin W, Wolfe GI, et al. Blunted circadian variation in autonomic regulation of sinus node function in veterans with Gulf War syndrome. Am J Med 2004; 117: 469-78
67. Jamal GA, Hansen S, Apartopoulos F, et al. The 'Gulf War syndrome': is there evidence of dysfunction in the nervous system? J Neurol Neurosurg Psychiatry 1996; 60: 449-51
68. Kelsall H, Macdonell R, Sim M, et al. Neurological status of Australian veterans of the 1991 Gulf War and the effect of medical and chemical exposures. Int J Epidemiol 2005; 34: 810-9
69. Rose MR, Sharief MK, Priddin J, et al. Evaluation of neuromuscular symptoms in UK Gulf War veterans: a controlled study. Neurology 2004; 63: 1681-7
70. Horner RD, Kamins KG, Feussner JR, et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology 2003; 61: 742-9
71. Haley RW. Excess incidence of ALS in young Gulf War veterans. Neurology 2003; 61: 750-6
72. Rose MR. Gulf War service is an uncertain trigger for ALS. Neurology 2003; 61: 730-1
73. Weisskopf MG, O'Reilly EJ, McCullough ML, et al. Prospective study of military service and mortality from ALS. Neurology 2005; 64: 32-7
74. Kang HK, Bullman TA. Mortality among US veterans of the Persian Gulf War: 7-year follow-up. Am J Epidemiol 2001; 154: 399-405
75. Macfarlane GJ, Thomas E, Cherry N. Mortality among UK Gulf War veterans. Lancet 2000; 356: 17-21
76. Donta ST, Engel CC, Guarino PP, et al. Cognitive behavioral therapy and aerobic exercise for Gulf War veterans' illnesses: a randomized controlled trial. JAMA 2003; 289 (11): 1396-404
77. Engel CC, Kayanan D, Roy M, et al. Multidisciplinary treatment of persistent symptoms after Gulf War service. Mil Med 1998; 163: 202-8
78. Gackstetter GD, Hooper TI, Al Qahtani MS, et al. Assessing the potential health impact of the 1991 Gulf War on Saudi Arabian National Guard Soldiers. Int J Epidemiol 2005; 34: 801-8
79. Weber W. France investigates Gulf War syndrome. Lancet 2000; 356: 1747
80. Hyams KC, Wignall FS, Roswell R. War syndromes and their evaluation: from the US Civil War to the Persian Gulf War. Ann Intern Med 1996; 125: 398-405
81. Jones E, Hodgins-Vermaas R, McCartney H, et al. Post-combat syndromes from the Boer war to the Gulf War: a cluster analysis of their nature and attribution. BMJ 2002; 324: 321-4
82. Hotopf M, Wessely S. Can epidemiology clear the fog of war? Lessons from the 1990-91 Gulf War. Int J Epidemiol 2005; 34: 791-800
83. Research Advisory Committee on Gulf War Veterans Illnesses. RAC-Gulf War Veterans' Illnesses (T-GW) US Department of Veterans Affairs [online]. Available from URL: http://www1.va.gov/RAC-GWVI/ [Accessed 2005 Aug 31]
84. Department of Defense. Report of the Defense Science Board Task Force on Persian Gulf War health effects, June 1994 [online]. Washington, DC: Office of the Under Secretary of Defense for Acquisition and Technology. 1994 Jun. Available from URL: http://www.gulflink.osd.mil/dsbrpt/ [Accessed 2005 Aug 31]
85. National Institutes of Health Technology Assessment Workshop Panel. The Persian Gulf experience and health. JAMA 1994; 272: 391-5
86. Presidential Advisory Committee on Gulf War Veterans' Illnesses: interim report [online]. Washington, DC: US Government Printing Office, 1996 Feb. Available from URL: http://www.gulflink.osd.mil/gwvi/7290_032.pdf [Accessed 2005 Aug 31]
87. Presidential Advisory Committee on Gulf War Veterans' Illnesses: final report [online]. Washington, DC, US Government Printing Office, 1996 Dec. Available from URL: http://www.gulflink.osd.mil/gwvi/toc-f.html [Accessed 2005 Aug 31]
88. Presidential Advisory Committee on Gulf War Veterans' Illnesses: special report [online]. Washington, DC: US Government Printing Office, 1997 Oct. Available from URL: http://www.gulflink.osd.mil/gwvi/cover.html [Accessed 2005 Aug 31]
89. Research Advisory Committee on Gulf War Veterans' Illnesses. Report and recommendations: scientific progress in understanding Gulf War veterans' illnesses [online]. 2004 Sep. Available from URL: http://www1.va.gov/rac-gwvi/ docs/ReportandRecommendations_2004.pdf [Accessed 2005 Aug 31]
90. The Rt Hon The Lord Lloyd of Berwick. Independent public inquiry on Gulf War Illnesses [online]. 2004 Nov 17. Available from URL: http://www.lloyd-gwii. com/ [Accessed 2005 Aug 31]
91. Deahl M. Smoke, mirrors, and Gulf War illness. Lancet 2005; 365: 635-8
92. Committee on Veterans' Affairs, United States Senate. Report of the Special Investigation Unit on Gulf War illnesses [online]. 1998. Available from URL: http://www.gulflink.osd.mil/library/senate/siu_index.html [Accessed 2005 Aug 31]
93. Parliamentary Office of Science and Technology. Gulf War illnesses: dealing with the uncertainties [online]. 1997 Dec Available from URL: http://www.parliament.uk/post/9712.htm [Accessed 2005 Oct 10]
94. Special Oversight Board for Department of Defense Investigations of Gulf War Chemical and Biological Incidents: final report. Washington, DC: Military Health System, 2000 Dec
95. Committee on the DoD Persian Gulf Syndrome Comprehensive Clinical Evaluation Program, Division of Health Promotion and Disease Prevention, Institute of Medicine. Evaluation of the US Department of Defense Persian Gulf comprehensive clinical evaluation program. Washington, DC: National Academy Press, 1995
96. Joellenbeck LM, Hernandez LM. The Institute of Medicine's independent scientific assessment of Gulf War health issues. Mil Med 2002; 167: 186-90
97. Board on Health Promotion and Disease Prevention, Institute Of Medicine of the National Academies. Gulf War and health. Vol. 3. Fuels, combustion products, and propellants. Committee on Gulf War and Health, literature review of selected environmental particulates, pollutants, and synthetic chemical compounds. Washington, DC: The National Academies Press, 2005
98. Board on Health Promotion and Disease Prevention, Institute of Medicine of the National Academies. Gulf War and Health: updated literature review of sarin. Committee on Gulf War and Health: updated literature review of sarin. Washington, DC: The National Academies Press, 2004
99. Board on Health Promotion and Disease Prevention, Institute Of Medicine of The National Academies. Gulf War and Health. Vol. 2. Insecticides and solvents. Committee on Gulf War and Health: literature review of pesticides and solvents. Washington, DC: The National Academies Press, 2003
100. Committee on Identifying Effective Treatments for Gulf War Veterans' Health Problems, Board on Health Promotion and Disease Prevention, Institute of Medicine. Gulf War veterans: treating symptoms and syndromes. Washington, DC: National Academy Press, 2001
101. Committee on Health Effects Associated with Exposures During the Gulf War, Division of Health Promotion and Disease Prevention. Gulf War and health. Vol. 1. Depleted uranium, pyridostigmine bromide, sarin, and vaccines. Washington, DC: National Academy Press, 2000
102. Committee on Health Effects Associated with Exposures During the Gulf War, Institute of Medicine. An assessment of the safety of the anthrax vaccine: a letter report. Washington, DC: Institute of Medicine, 2000
103. Committee on Strategies to Protect the Health of Deployed U.S. Forces. Institute of Medicine. Protecting those who serve: strategies to protect the health of deployed U.S. forces. Washington, DC: National Academy Press, 2000
104. Division of Military Science and Technology, Commission on Engineering and Technical Systems, Board on Environmental Studies and Toxicology, Commission on Life Sciences, National Research Council. Strategies to protect the health of deployed U.S. forces: detecting, characterizing, and documenting exposures. Washington, DC: National Academy Press, 2000
105. Committee on Measuring the Health of Gulf War Veterans, Division of Health Promotion and Disease Prevention, Institute of Medicine. Gulf War veterans: measuring health. Washington, DC: National Academy Press, 1999
106. Medical Follow Up Agency, Institute of Medicine. Strategies to protect the health of deployed U.S. forces: medical surveillance, record keeping, and risk reduction. Washington, DC: National Academy Press, 1999
107. Committee on a National Center on War-Related Illnesses and Postdeployment Health Issues, Division of Health Promotion and Disease Prevention, Institute of Medicine. National center for military deployment health research. Washington, DC: National Academy Press, 1999
108. Committee on Measuring the Health of Persian Gulf Veterans, Division of Health Promotion and Disease Prevention, Institute of Medicine. Measuring the health of Persian Gulf veterans: workshop summary. Washington, DC: National Academy Press, 1998
109. Committee on the Evaluation of the Department of Veterans Affairs Uniform Case Assessment Protocol, Division of Health Promotion and Disease Prevention, Institute of Medicine. Adequacy of the VA Persian Gulf Registry and uniform case assessment protocol. Washington, DC: National Academy Press, 1998
110. Committee on the Evaluation of the Department of Defense Comprehensive Clinical Evaluation Program, Division of Health Promotion and Disease Prevention, Institute of Medicine. Adequacy of the comprehensive clinical evaluation program: a focused assessment. Washington, DC: National Academy Press, 1997
111. Committee on the Evaluation of the Department of Defense Comprehensive Clinical Evaluation Program, Division of Health Promotion and Disease Prevention, Institute of Medicine. Adequacy of the comprehensive clinical evaluation program: nerve agents. Washington, DC: National Academy Press, 1997
112. Committee to Review the Health Consequences of Service During the Persian Gulf War, Medical Follow Up Agency, Institute of Medicine. Health consequences of service during the Persian Gulf War: recommendations for research and information systems. Washington, DC: National Academy Press, 1996
113. Committee to Review the Health Consequences of Service During the Persian Gulf War, Medical Follow Up Agency, Institute of Medicine. Health consequences of service during the Persian Gulf War: initial findings and recommendations for immediate action. Washington, DC: National Academy Press, 1995
114. Institute of Medicine of the National Academies [online]. Available from URL: http://www.iom.edu/ [Accessed 2005 Aug 31]
115. What is the Royal Society for? Lancet 2005; 365: 1746
116. Brown M. The role of science in department of veterans affairs disability compensation policies for environmental and occupational illnesses and injuries. Brooklyn J Law Policy 2005; 13 (2): 593-612
117. Institute of Medicine. Gulf War and health. Vol. 1. In: Fulco CE, Liverman CT, Sox HC, editors. Depleted uranium, sarin, pyridostigmine bromide, vaccines. Washington, DC: National Academy Press, 2000 [online]. Available from URL: http://books.nap.edu/catalog/9953.html [Accessed 2005 Aug 31]
118. McDiarmid MA, Engelhardt S, Oliver M, et al. Health effects of depleted uranium on exposed Gulf War veterans: a 10-year follow-up. J Toxicol Environ Health A 2004; 67: 277-96
119. McDiarmid MA, Squibb K, Engelhardt SM. Related articles, biologic monitoring for urinary uranium in gulf war I veterans. Health Phys 2004; 87: 51-6
120. McDiarmid MA, Engelhardt SM, Oliver M, et al. Biological monitoring and surveillance results of Gulf War I veterans exposed to depleted uranium. Int Arch Occup Environ Health. Epub 2005 Aug 2
121. Squibb KS, Leggett RW, McDiarmid MA. Prediction of renal concentrations of depleted uranium and radiation dose in Gulf War veterans with embedded shrapnel. Health Phys 2005; 89: 267-73
122. Metcalf DR, Holmes JH. EEG, psychological, and neurological alterations in humans with organophosphorous exposure. Ann N Y Acad Sci 1969; 160: 357-85
123. Morita H, Yanagisawa N, Nakajima T, et al. Sarin poisoning in Matsumoto, Japan. Lancet 1995; 346: 290-3
124. Murata K, Araki S, Yokoyama K, et al. Asymptomatic sequelae to acute sarin poisoning in the central and autonomic nervous system 6 months after the Tokyo subway attack. J Neurol 1997; 244: 601-6
125. Brown MA, Brix KA. Review of health consequences from high-, intermediate-and low-level exposure to organophosphorus nerve agents. J Appl Toxicol 1998; 18: 393-408
126. Brachman PS, Gold H, Plotkin S, et al. Field evaluation of a human anthrax vaccine. Am J Public Health 1962; 52: 632-45
127. White CS, Adler WH, McGann VG. Repeated immunization: possible adverse effects. Reevaluation of human subjects at 25 years. Ann Intern Med 1974; 81: 594-600
128. Hotopf M, David A, Hull L, et al. Role of vaccinations as risk factors for ill health in veterans of the Gulf War: cross sectional study. BMJ 2000; 320: 1363-7
129. Shaheen S. Shots in the desert and Gulf War syndrome: evidence that multiple vaccinations during deployment are to blame is inconclusive. BMJ 2000; 320: 1351-2
130. United States Army. Final report: Kuwait oil fire health risk assessment, no. 39.26-L192-91, 5 May-3 Dec 1991. Aberdeen Proving Ground (MD): Department of the Army, US Army Environmental Hygiene Agency, 1994
131. Petruccelli BP, Goldenbaum M, Scott B, et al. Health effects of the 1991 Kuwait oil Fires: a survey of US army troops. J Occup Environ Med 1999; 41: 433-9
132. Department of Defense. Environmental exposure report: oil well fires [online]. Available from URL: http://www.gulflink.osd.mil/owf_ii/ [Accessed 2005 Aug 31]
133. United States General Accounting Office (GAO). Gulf War illnesses: DOD's conclusions about US troops' exposure cannot be adequately supported [on-line]. GAO-04-821T, June 1, 2004. Available from URL: www.gao.gov/cgi-bin/getrpt?.GAO- 04-821T [Accessed 2005 Aug 31]
134. Hyams KC, Riddle R, Trump D, et al. Endemic infectious diseases and biological warfare during the Gulf War: a decade of analysis and final concerns. Am J Trop Med Hyg 2001; 65: 664-70
135. Friedman A, Kaufer D, Shemer J, et al. Pyridostigime brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat Med 1996; 2: 1382-5
136. Lallement G, Foquin A, Baubichon D, et al. Heat stress, even extreme, does not induce penetration of pyridostimine into the brain of guinea pigs. Neurotoxicology 1998; 19: 759-66
137. Grauer E, Alkalai D, Kapon J, et al. Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration. Toxicol Appl Pharmacol 2000; 164: 301-4
138. Sinton CM, Fitch TE, Petty F, et al. Stressful manipulations that elevate corticosterone reduce blood-brain permeability to pyridostigmine in the rat. Toxicol Appl Pharmacol 2000; 165: 99-105
139. Armed Forces Epidemiological Board (AFEB) [online]. Available from URL: http://www.ha.osd.mil/afeb/ [Accessed 2005 Aug 31]
140. Brown MA, Murphy FM, Mather SH. Innovation in veterans' health care and assistance: The Department of Veterans Affairs 10 years after the Gulf War. Mil Med 2002; 167: 191-5
141. Gronseth GS. Gulf War syndrome: a toxic exposure? A systematic review. Neurol Clin 2005; 23: 523-40